December, 16 2025 Tuesday 12:12 Hrs
Last update 11-9-2025
  • SENSEX :   84,733.65

  • Top commodity trading and broking companies in India-479.71( -0.56%) 16-Dec-2025
top-arrow-market
Sensex 84718.9 -494.46  (-0.58) 16-Dec-2025
Previous Day Close
85213.36
Today's High/Low
High Low
  •  
  •  
85059.96 84683.91

Company News Details

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
137.4709721
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
57.72
6332.94
EPS(TTM)
Face Value()
Div & Yield %
5.61
1
0.15
 

Shilpa Medicare receives eight USFDA observations for Jadcherla facility
Nov 24,2025
According to an exchange filing, the ten-day inspection of the facility, conducted from 12 November to 21 November 2025, concluded with the issuance of the Form 483 with eight observations. None of the observations have been categorized as repeat observations.

The facility is capable of manufacturing, packaging, testing, storing, and distributing sterile injectables, oral tablets, and capsules, supplying products to the US, Europe, and other global markets. The company said US sales from this plant accounted for less than 1% of its total business in H1 FY25-26 and less than 5% in FY24-25.

The unit is approved by major regulatory authorities, including EMA (Europe), Health Canada, Anvisa (Brazil), and TGA (Australia). Shilpa Medicare added that it will respond comprehensively to the inspectional observations within the stipulated timeline.

Shilpa Medicare is a manufacturer of API, formulation, and development services. The company's consolidated net profit surged 145.7% to Rs 44.07 crore in Q2 FY26 as against Rs 17.94 crore recorded in Q2 FY25. Revenue rose 7.6% YoY to Rs 369.97 crore in the quarter ended 30 September 2025.

The counter rose 0.57% to Rs 352.80 on the BSE.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.